what is glp 1 and gip New strategies for the treatment of obesity metabolic dysfunctions GLP-1/GIP Receptor Agonists and Diabetic

Tirzepatide functions similarly to semaglutide and also promotes significant weight loss

Autoimmune diseases like Lupus, Myasthenia Gravis, and more, where the immune system mistakenly targets healthy tissues

Overexpression of proinflammatory cytokines during COVID-19 results in cytokine storm, which ultimately leads to the clinical development of ALI and ARDS

Transport Folate and its coenzymes require transporters to cross cell membranes

Conclusion Diarrhea on a GLP1 medication is common, especially during the first weeks and after dose increases

If after twelve weeks there is no improvement in fat mass or functional markers, it is reasonable to stop and reassess